Navigation Links
Forte Research Systems Unveils the Allegro™ Research on Demand Cloud-Based Product Line
Date:11/18/2010

MADISON, Wis., Nov. 18, 2010 /PRNewswire/ -- Forte Research Systems, makers of OnCore® , the most widely adopted clinical research platform among academic research organizations and cancer centers in the United States, unveiled a new product line today, the Allegro™ Research on Demand, cloud-based clinical research management solution. The first product in the new line is Allegro CTMS@Site™, the clinical trials management system built exclusively for investigational sites.

(Photo: http://photos.prnewswire.com/prnh/20101118/CG04162)

(Photo: http://www.newscom.com/cgi-bin/prnh/20101118/CG04162)

(Logo: http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20101115/CG02078LOGO)

Research coming out of Tufts Center for the Study Drug Development shows that over half of the clinical research being conducted worldwide is taking place in physician practices, community hospitals, and dedicated research sites. These relatively small sites are experiencing trends in the industry in ways that are distinct from large research organizations.

"Trends in the industry are creating a significant increase in administrative overhead and regulatory exposure for the sites," said Srini Kalluri, founder, president & CEO of Forte Research Systems. "We built Allegro CTMS@Site to address these specific challenges from the sites' perspective."

Pharmaceutical companies conducting clinical trials on new drugs are spreading the work among more sites as a way to increase the probability of success and to reach more potential patient participants. In turn, this trend has led individual sites to take on more trials. At the same time, while sites are grappling with more trials, the trials are becoming much more complex with a proliferation of procedures and subject eligibility criteria.

In an attempt to be more competitive and efficient in this environment, today's sites are implementing tighter financial management, overseeing regulatory compliance more intensively, striving to achieve status as a preferred partner, and adopting clinical trials management systems (CTMS) to streamline operations and replace paper-based processes.

"When it comes to CTMS, current solutions in the marketplace leave a lot to be desired," said Kalluri.

With what is currently available, sites have to choose between products with bloated functionality and complex interfaces that require up-front investments in infrastructure, have ongoing maintenance and administrative overhead, and have long training cycles with slow user adoption rates.

By contrast, the Allegro product line is built for clinical research operations excellence with no software to install and no systems administration required, real-time visibility into the entire clinical research portfolio, and a user-centric, intuitive interface that is easy to use, virtually eliminating the need for training. With Allegro CTMS@Site, sites can get up and running in a single day.

Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research Systems, Inc. develops clinical and translational research management software. The company's flagship product, the OnCore® system, is the nation's most widely adopted clinical research platform among academic research organizations and cancer centers.

PercipEnz Technologies is now Forte Research Systems. Same company, new name.


'/>"/>
SOURCE Forte Research Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New FORTEO® and EVISTA® Data to be Presented at Premiere Scientific Meeting for Bone and Mineral Research
2. ForteBio Announces Launch of Protein G Biosensor for Use on Companys Octet® Instruments
3. Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTA™ for Men With Low Testosterone
4. ForteBio Launches New Dip and Read(TM) Residual Protein A Detection Kit; Introduces Sidekick(TM) Offline Biosensor Immobilization Station for All Octet(R) Instruments
5. FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
6. Neuro Kinetics Receives HHS Therapeutic Discovery Grant to Further Research Into Early Diagnosis of Sports Concussions
7. Access Pharmaceuticals ProLindac™ and CobaCyte™ Oncology Research Displayed at the Innovations in Cancer Prevention and Research Conference, November 17-19, 2010
8. MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
9. CVS Caremark Research Finds Correlation Between Amount of Patient Co-pay and Prescription Abandonment
10. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
11. New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... January 19, 2017 Pfizer ... the Milner Therapeutics Consortium   Major ... Cambridge   The Milner ... PFE ) as a partner to the Milner Therapeutics ... enables the efficient transfer of materials between industry and ...
(Date:1/19/2017)... 18, 2017  ViewRay, Inc. (Nasdaq: ... only clinical MRI-guided radiation therapy system, announced today that ... $26.1 million through a private placement of its ... the financing and was joined by certain of ... Kearny Venture Partners, and an additional new institutional ...
(Date:1/19/2017)... Jan. 18, 2017 The Academy of ... Drug Administration (FDA) for its release today of ... health decision makers can proactively share clinical and ... well as emerging therapies awaiting FDA approval. ... recommendations that AMCP developed during two multi-stakeholder meetings ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy ... enhancement of their 503A compounding pharmacy located in Ocala, Florida. , Meeting ... and patients throughout the United States for high-quality human anti-aging and wellness ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... Somerset, N.J. (PRWEB) , ... January 19, 2017 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... Medicines with Lipids,” with Gattefossé, the leader in innovative excipients and drug delivery ...
(Date:1/19/2017)... ... January 19, 2017 , ... In 2009, ... fillers that resulted in severe facial disfiguration. After four frightening years of isolation ... at UCLA Medical Center, who removed the substances in a partial facial transplant ...
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate Medical Academy (UMA) ... are passionate about making a difference in the lives of the next generation ... a nonprofit healthcare educational institution, has more than 30,000 alumni and employs more ...
Breaking Medicine News(10 mins):